DRSK

Aptus Defined Risk ETF

An actively-managed strategy that seeks income and growth through a hybrid fixed income and equity approach. The strategy invests 90-95% of its assets to obtain exposure to investment-grade corporate bonds, with the remainder seeking gains in long-term in-the-money call options on selective large cap stocks and sectors.

Why DRSK?

  • Broadly diversified income from intermediate-term, investment-grade corporate bonds without chasing yield or accepting long-duration risk
  • Laddered approach to create annual redemption and redeployment to reduce reinvestment risk
  • Intermediate-term options enable pursuit of 10-20 equity market opportunities, typically with 5-10% of capital at risk

Fund Details

Current as of 01/19/2022

Fund TickerDRSK
Fund NameAptus Defined Risk ETF
Primary ExchangeCboe
CUSIP26922A388
ISINUS26922A3885
Net Assets843069683.85
Expense Ratio0.79%
30 Day Median Bid- Ask %0.14
Inception Date08/07/2018
Shares Outstanding 29550000.000
DistributorQuasar Distributors
AdvisorAptus Capital Advisors

*Premium Discount Disclaimer

The following Frequency Distribution of Premiums and Discounts chart is provided to show the frequency at which the closing price of the Fund was at a premium (above) or discount (below) to their daily net asset value (NAV). The chart represents past performance and cannot be used to predict future results. Shareholders may pay more than NAV when buying Fund shares and receive less than NAV when those shares are sold because shares are bought and sold at current market prices.

Fund Objectives

The Aptus Defined Risk ETF seeks current income and capital appreciation.

Fund Prices

Current as of 01/19/2022

 NAV MARKET PRICE
Net Asset Value28.53Closing Price28.52
Daily Change $-0.07Daily Change $-0.08
Daily Change %-0.23Daily Change %-0.26
Premium/Discount %-0.04

Fund holdings are subject to change and should not be considered a recommendation to buy or sell any security.

Fund Distributions

EX-DATERECORD
DATE
PAYABLE
DATE
INCOMESHORT TERM
CAPITAL GAIN
LONG TERM
CAPITAL GAIN
12/29/2112/30/2112/31/21$0.0842
11/17/2111/18/2111/19/21$0$0.4405$0.0937
9/14/219/15/219/16/21$0.0565
6/15/216/16/216/17/21$0.0441
3/16/213/17/213/18/21$0.0426
12/29/2012/30/2012/31/20$0.1136
11/18/2011/19/2011/20/20$0$1.1350$0.1750
9/14/209/15/209/17/20$0.1130
6/16/206/17/206/18/20$0.0630
3/17/203/18/203/19/20$0.0710
12/30/1912/31/191/2/20$0.1136$0.3154
9/17/199/18/199/19/19$0.0978
6/11/196/12/196/13/19$0.1347
3/12/193/13/193/14/19$0.0840
12/28/1812/31/181/02/19$0.1451$0.47
9/18/189/19/189/20/18$0.0382

This fund is expected to pay at least one more distribution before year end. The figures represent estimates and are subject to change based on portfolio, market, and shareholder activity and tax adjustments. Actual distributions will be based on shares outstanding as of the record date. The net asset value of a fund with a distribution will drop on the ex-date by the amount of the distribution. Keep in mind that market conditions, portfolio changes and/or changes in outstanding fund shares could affect these estimates substantially. This information is NOT FINAL and is subject to change until the ex-dividend date. All data subject to change. Actual distributions will be posted on the aptusetfs.com site after each fund’s ex-dividend date. Aptus does not provide tax, accounting or legal advice. Any tax statements contained herein were not intended or written to be used, and cannot be used for the purpose of avoiding U.S., federal, state or local tax penalties. Clients should consult their advisor as to any tax, accounting or legal statements made herein. Specific questions regarding your clients’ personal income tax situation should be referred to a tax advisor. 

Fund Performance

 Monthly
as of 12/31/2021
Quarterly
as of 12/31/2021
NAV %Market %NAV %Market %
1 Month0.370.430.370.43
3 Month 2.512.912.512.91
1 Year0.750.880.750.88
3 Year9.048.969.048.96
5 Year----
YTD0.750.880.750.88
Since Inception32.3932.5032.3932.50
Since Inception Annualized8.608.638.608.63

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period. Performance is annualized for periods greater than 1 year.

Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted. Short-term performance in particular is not a good indication of the fund’s future performance and an investment should not be made solely on returns.

Fund Holdings

Current as of 01/19/2022

account_tickerstock_tickercusipsecurity_descsharespricemarket_valueweightingseffective_date
DRSKIBDN46434VBA7ISHARES TR IBONDS DEC22 ETF5686286.0025.120000142839504.3216.98%01/21/2022
DRSKIBDO46434VAX8ISHARES TR IBONDS DEC23 ETF7452308.0025.590000190704561.7222.67%01/21/2022
DRSKIBDP46434VBG4ISHARES TR IBONDS DEC24 ETF6401191.0025.730000164702644.4319.58%01/21/2022
DRSKIBDQ46434VBD1ISHARES TR IBONDS DEC25 ETF6752368.0026.100000176236804.8020.95%01/21/2022
DRSKIBDR46435GAA0ISHARES TR IBONDS DEC20263648887.0025.66000093630440.4211.13%01/21/2022
DRSKMOS 220318C00050000MOS 220318C00050000THE MOSA CLL OPT 3/22 5030000.000.5600001680000.000.20%01/21/2022
DRSKMOS 220318C00060000MOS 220318C00060000THE MOSA CLL OPT 3/22 60-30000.000.095000-285000.00-0.03%01/21/2022
DRSKQQQ 220121C00380000QQQ 220121C00380000INVESCO CLL OPT 1/22 3803000.000.03500010500.000.00%01/21/2022
DRSKQQQ 220204C00390000QQQ 220204C00390000INVESCO CLL OPT 2/22 3905000.000.465000232500.000.03%01/21/2022
DRSKQQQ 220204C00400000QQQ 220204C00400000INVESCO CLL OPT 2/22 400-5000.000.165000-82500.00-0.01%01/21/2022
DRSKSPX 220121C04800000SPX 220121C04800000CBOE S&P CLL OPT 1/22 4800800.000.0250002000.000.00%01/21/2022
DRSKSPX 220121C04850000SPX 220121C04850000CBOE S&P CLL OPT 1/22 4850-800.000.025000-2000.000.00%01/21/2022
DRSKSPX 220218P04500000SPX 220218P04500000CBOE S&P PUT OPT 2/22 4500550.00123.3500006784250.000.81%01/21/2022
DRSKSPX 220318C04700000SPX 220318C04700000CBOE S&P CLL OPT 3/22 4700700.0038.7000002709000.000.32%01/21/2022
DRSKSPXW 220121C04630000SPXW 220121C04630000CBOE S&P CLL OPT 1/22 46301000.000.45000045000.000.01%01/21/2022
DRSKSPXW 220121C04680000SPXW 220121C04680000CBOE S&P CLL OPT 1/22 4680-1000.000.200000-20000.000.00%01/21/2022
DRSKSPXW 220121C04750000SPXW 220121C04750000CBOE S&P CLL OPT 1/22 4750800.000.1000008000.000.00%01/21/2022
DRSKSPXW 220121C04800000SPXW 220121C04800000CBOE S&P CLL OPT 1/22 4800-800.000.025000-2000.000.00%01/21/2022
DRSKXLE 220318C00066000XLE 220318C00066000ENERGY S CLL OPT 3/22 6615000.002.1500003225000.000.38%01/21/2022
DRSKXLE 220318C00073000XLE 220318C00073000ENERGY S CLL OPT 3/22 73-7500.000.555000-416250.00-0.05%01/21/2022
DRSKXLF 220318C00043000XLF 220318C00043000FINANCIA CLL OPT 3/22 4340000.000.170000680000.000.08%01/21/2022
DRSKCash&OtherCash&OtherCash & Other57707017.001.00000057707017.006.86%01/21/2022